TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
TVRD

Tvardi Therapeutics, Inc.

Healthcare · Biotechnology

1.30$ +19.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TVRD
Line item 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
71.9% 70.1% 97.8% 96.9% 100.0% 98.3%
11.7% 5.4% 47.7% 84.9% 86.5% 64.6%
66.7% 67.6% 97.0% 84.9% 86.5% 96.1%
0.8% 0.5% 9.9% 14.9% 10.3% –
– 1.0% – – 2.1% –
– – 1.1% 1.7% 0.9% 1.0%
8.2% 7.9% 199.9% 329.8% 110.5% 34.7%
6.8% 7.1% 9.5% 12.2% 9.1% 34.4%
0.6% 0.7% 4.4% 0.3% – 0.4%
1.8% 2.3% 5.3% 6.0% 3.3% 10.0%
– – – – 69.0% –
91.8% 92.1% -99.9% -229.8% -10.5% 65.3%
-144.7% -194.6% -100.9% -232.7% -1,724.1% -344.4%
0.5% 0.6% 20.7% 34.6% 3.5% 24.3%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?